new molecules and indications for glp-1 medicines Safety-focused summary of receptor agonists in diabetes, obesity, beyond GLP-1 receptor agonists in the

Changes in Adult Obesity Trends in the US

Lv M, Xue G, Cheng H, Meng P, Lian X, Holscher C, et al

Court of Appeals for the First Circuit upheld Cignas right to exclude weight-loss drug coverage without it constituting disability discrimination. What Does This Mean If You Have Diabetes vs

Most commercial insurance plans require prior authorization for GLP-1 weight loss medications

After a thorough evaluation, we provide guidance on the best treatment plan, combining GLP-1 therapy with hormone replacement therapy (HRT) and other solutions for lasting results

Caspase and TUNEL assays INS-1 832/3 cells were exposed overnight to thapsigargin (1 M) in serum-free RPMI plus 11 mM glucose